Savient Drug Auction Doubles Price: Bankruptcy - Bloomberg

12/12/13


Drug Discovery & Development

Savient Drug Auction Doubles Price: Bankruptcy
Bloomberg
Savient Pharmaceuticals Inc. (SVNTQ), a developer of a treatment for gout, held an auction this week where the price more than doubled, with the winning bid of $120.4 million made by Crealta Pharmaceuticals LLC. A hearing to approve the sale will take ...
Savient acquired by Crealta Pharmaceuticals in $120M bankruptcy auctionNJBIZ
Bankrupt Savient Takes $120M Bid From Pharma Co. CrealtaLaw360 (subscription)
Savient attracts a buyer willing to get it out of bankruptcy courtFiercePharma
Businessweek -PharmaTimes -Sacramento Bee
all 21 news articles »

[more]